![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Saturday, September 02, 2017 2:16:25 PM
Followers of this board recognize frequent, persisting posters, of which I’m one.
A number of us would be, by others, inaccurately characterized as “pumpers,” people who post imaginatively positive and glowing reports of future successes of the company we support (Anavex Life Science Corp).
In the middle, quiet infrequently now, are incidental posters merely asking good questions or expressing middle-of-the-road perspectives on the company and its future.
Then, a few others rather consistently post warnings about Anavex’s future, questioning its science, management, funding, or other factors they believe will obviate any future successes. For them, an investment in AVXL shares is either unwise, or plainly risky.
I’m reasonably competent in science. I’ve parsed the extensive peer-reviewed, published literature on the Anavex science, along with the company’s presentations on the subject. Personally, I’m convinced of the company’s great future. With discretionary funds, ones I can lose without affecting my family finances in any way, I’ve taken a small AVXL position. I think it will eventually be very rewarding.
I’m pleased to post my perceptions of Anavex science and the therapeutic and financial outcomes it will result in.
But the several Anavex naysayers here are frequent and consistent in their misgivings and warning about the company and it’s so-questionable molecules.
Those postings allow me to sleep well each night. I don’t want any un-knowing newbie to come here, see my postings alone, and turn right around and bet the ranch on an Anavex future.
Those who ponder and agree with my Anavex perspectives are advised to invest only discretionary funds in AVXL shares — if any at all. It’s a matter each reader will have to decide upon personally and responsibly, of course.
How, then, shall it be in a year or so? Will Anavex have gained FDA approval for the treatment of Rett syndrome, Alzheimer’s disease, and Parkinson’s, and thereby become a major profit-making and dividend-producing pharmaceutical? Or, as so strongly implied by the few Anavex skeptics who so consistently post here will all of us who have taken AVXL positions have lost our investments as Anavex Life Science Corp devolves into bankruptcy?
If it’s the former (I am convinced that it is), I’ll make no posted references to the skeptical postings that will have proven to be so inaccurate.
If it’s the latter, where I’ve lost my small investment and Anavex goes bust, I’ll be sordidly interested in whatever “told-you-so” postings that might appear, if any.
The main thing is this. Every perspective on Anavex is available here. Everyone must conduct his own, detailed due diligence. After spending some time reading the Anavex Ihub postings, no one should be making any ignorant, low-information investments in the company. Many perhaps, have decided to stay away from an AVXL purchase, not wishing to take on the perceived risks of such.
Therefore, I sleep confidently each evening. Investments in AVXL, or decisions against them, are, from this board, well-formed.
I wish for everyone the best personal outcomes with their Anavex decisions, whatever they might be. The information for such is readily available.
Recent AVXL News
- Anavex Life Sciences to Present at the H.C. Wainwright 5th Annual Neuro Perspectives Virtual Conference • GlobeNewswire Inc. • 06/20/2024 11:30:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/17/2024 11:30:10 AM
- Anavex Life Sciences Announces Expansion of Leadership Team • GlobeNewswire Inc. • 05/22/2024 11:30:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/17/2024 10:01:00 AM
- Anavex Life Sciences to Present at the H.C. Wainwright 2nd BioConnect Investor Conference at NASDAQ • GlobeNewswire Inc. • 05/14/2024 11:30:00 AM
- Shareholders that lost money on Anavex Life Sciences Corporation(AVXL) Urged to Join Class Action - Contact The Gross Law Firm to Learn More • PR Newswire (US) • 05/10/2024 09:45:00 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/09/2024 08:35:55 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/09/2024 12:00:30 PM
- Anavex Life Sciences Reports Fiscal 2024 Second Quarter Financial Results and Provides Business Update • GlobeNewswire Inc. • 05/09/2024 11:30:00 AM
- The Gross Law Firm Announces the Filing of a Securities Class Action on Behalf of Anavex Life Sciences Corporation(AVXL) Shareholders • PR Newswire (US) • 05/07/2024 09:45:00 AM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 05/06/2024 10:03:33 AM
- Anavex Life Sciences Corporation Sued for Securities Law Violations - Contact The Gross Law Firm Before May 13, 2024 to Discuss Your Rights - AVXL • PR Newswire (US) • 05/03/2024 09:45:00 AM
- Anavex Life Sciences to Announce Fiscal 2024 Second Quarter Financial Results on Thursday, May 9th, 2024 • GlobeNewswire Inc. • 05/02/2024 11:30:00 AM
- May 13, 2024 Deadline: Contact The Gross Law Firm to Join Class Action Suit Against AVXL • PR Newswire (US) • 04/26/2024 09:45:00 AM
- Contact The Gross Law Firm by May 13, 2024 Deadline to Join Class Action Against Anavex Life Sciences Corporation(AVXL) • PR Newswire (US) • 04/19/2024 09:45:00 AM
- The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of May 13, 2024 in Anavex Life Sciences Lawsuit - AVXL • PR Newswire (US) • 04/16/2024 09:45:00 AM
- Class Action Filed Against Anavex Life Sciences Corporation (AVXL) - May 13, 2024 Deadline to Join - Contact The Gross Law Firm • PR Newswire (US) • 04/12/2024 09:45:00 AM
- Anavex Life Sciences to Present at the Noble Capital Markets Virtual Healthcare Equity Conference • GlobeNewswire Inc. • 04/11/2024 11:30:00 AM
- Class Action Filed Against Anavex Life Sciences Corporation (AVXL) - May 13, 2024 Deadline to Join - Contact The Gross Law Firm • PR Newswire (US) • 04/09/2024 09:45:00 AM
- Anavex Life Sciences Corporation Class Action: The Gross Law Firm Reminds Anavex Life Sciences Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of May 13, 2024 - AVXL • PR Newswire (US) • 04/05/2024 09:45:00 AM
- Shareholders that lost money on Anavex Life Sciences Corporation(AVXL) should contact The Gross Law Firm about pending Class Action - AVXL • PR Newswire (US) • 04/02/2024 09:45:00 AM
- Lost Money on Anavex Life Sciences Corporation(AVXL)? Join Class Action Suit Seeking Recovery - Contact The Gross Law Firm • PR Newswire (US) • 03/29/2024 09:45:00 AM
- Investors who lost money on Anavex Life Sciences Corporation(AVXL) should contact The Gross Law Firm about pending Class Action - AVXL • PR Newswire (US) • 03/26/2024 09:45:00 AM
- Anavex Life Sciences to Present at the 23rd Annual Needham Virtual Healthcare Conference • GlobeNewswire Inc. • 03/25/2024 11:30:00 AM
Cannabix Technologies and Omega Laboratories Inc. Provide Positive Developments on Marijuana Breathalyzer Testing • BLO • Jul 11, 2024 8:21 AM
ECGI Holdings Enhances Board with Artificial Intelligence (AI) Expert Ahead of Allon Apparel Launch • ECGI • Jul 10, 2024 8:30 AM
Avant Technologies to Meet Unmet Needs in AI Industry While Addressing Sustainability Concerns • AVAI • Jul 10, 2024 8:00 AM
Panther Minerals Inc. Launches Investor Connect AI Chatbot for Enhanced Investor Engagement and Lead Generation • PURR • Jul 9, 2024 9:00 AM
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM